These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12359858)

  • 1. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.
    Wang F; Hansen RK; Radisky D; Yoneda T; Barcellos-Hoff MH; Petersen OW; Turley EA; Bissell MJ
    J Natl Cancer Inst; 2002 Oct; 94(19):1494-503. PubMed ID: 12359858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology.
    Wang F; Weaver VM; Petersen OW; Larabell CA; Dedhar S; Briand P; Lupu R; Bissell MJ
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14821-6. PubMed ID: 9843973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells.
    Liu H; Radisky DC; Wang F; Bissell MJ
    J Cell Biol; 2004 Feb; 164(4):603-12. PubMed ID: 14769856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.
    Castelló-Cros R; Khan DR; Simons J; Valianou M; Cukierman E
    BMC Cancer; 2009 Mar; 9():94. PubMed ID: 19323811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
    Rusnak DW; Lackey K; Affleck K; Wood ER; Alligood KJ; Rhodes N; Keith BR; Murray DM; Knight WB; Mullin RJ; Gilmer TM
    Mol Cancer Ther; 2001 Dec; 1(2):85-94. PubMed ID: 12467226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways differently regulate retinal pigment epithelial cell-mediated collagen gel contraction.
    Bando H; Ikuno Y; Hori Y; Sayanagi K; Tano Y
    Exp Eye Res; 2006 Mar; 82(3):529-37. PubMed ID: 16289050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion.
    Lin VC; Woon CT; Aw SE; Guo C
    Endocrinology; 2003 Dec; 144(12):5650-7. PubMed ID: 12970168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase.
    Adelsman MA; McCarthy JB; Shimizu Y
    Mol Biol Cell; 1999 Sep; 10(9):2861-78. PubMed ID: 10473632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Normanno N; De Luca A; Maiello MR; Campiglio M; Napolitano M; Mancino M; Carotenuto A; Viglietto G; Menard S
    J Cell Physiol; 2006 May; 207(2):420-7. PubMed ID: 16419029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
    Sobolik T; Su YJ; Wells S; Ayers GD; Cook RS; Richmond A
    Mol Biol Cell; 2014 Mar; 25(5):566-82. PubMed ID: 24403602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways.
    Price DJ; Avraham S; Feuerstein J; Fu Y; Avraham HK
    Cell Commun Adhes; 2002; 9(2):87-102. PubMed ID: 12487410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.
    Weaver VM; Petersen OW; Wang F; Larabell CA; Briand P; Damsky C; Bissell MJ
    J Cell Biol; 1997 Apr; 137(1):231-45. PubMed ID: 9105051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
    Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
    Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
    Choi C; Kwon J; Lim S; Helfman DM
    Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD93 regulates breast cancer growth and vasculogenic mimicry through the PI3K/AKT/SP2 signaling pathway activated by integrin β1.
    Liu H; Zhang J; Zhao Y; Fan Z; Yang Y; Mao Y; Yang J; Ma S
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23688. PubMed ID: 38511888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
    Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.